[HTML][HTML] “COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental …
Objectives In the context of the ongoing overdose crisis, a stark increase in toxic drug deaths
from the unregulated street supply accompanied the onset of the COVID-19 pandemic …
from the unregulated street supply accompanied the onset of the COVID-19 pandemic …
Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario
Background: London InterCommunity Health Centre (LIHC) launched a safer opioid supply
(SOS) program in 2016, where clients are prescribed pharmaceutical opioids and provided …
(SOS) program in 2016, where clients are prescribed pharmaceutical opioids and provided …
Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada
S Mayer, J Boyd, N Fairbairn, J Chapman… - International Journal of …, 2023 - Elsevier
Background Injectable opioid agonist treatment (iOAT) has recently been expanded in some
geographical contexts in Canada as part of a response to the escalating overdose crisis …
geographical contexts in Canada as part of a response to the escalating overdose crisis …
How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders' perspectives
T Magel, E Matzinger, S Blawatt… - … Prevention and Policy, 2024 - Taylor & Francis
Background Addressing inadequacies in the implementation of existing evidence-based
approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative …
approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative …
[HTML][HTML] Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study
Background Rural and smaller urban settings in Canada are disproportionately impacted by
the overdose crisis, highlighting the need for novel public health interventions within these …
the overdose crisis, highlighting the need for novel public health interventions within these …
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing
MTH Harris, RK Seliga, N Fairbairn, S Nolan… - International Journal of …, 2021 - Elsevier
Abstract Background The Ottawa Inner City Health's Managed Opioid Program is the first, to
our knowledge, to pair injectable opioid agonist hydromorphone treatment with assisted …
our knowledge, to pair injectable opioid agonist hydromorphone treatment with assisted …
[HTML][HTML] Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review
N Bozinoff, VS Tardelli, DS Rubin-Kahana… - Harm reduction journal, 2022 - Springer
Abstract Background and Aims Given the ongoing opioid crisis, novel interventions to treat
severe opioid use disorder (OUD) are urgently needed. Injectable opioid agonist therapy …
severe opioid use disorder (OUD) are urgently needed. Injectable opioid agonist therapy …
Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: a qualitative study of patient experiences in Vancouver, Canada
S Mayer, A Fowler, I Brohman, N Fairbairn… - International Journal of …, 2020 - Elsevier
Background Within the context of the ongoing overdose crisis and limitations of conventional
opioid treatments, the scale-up of injectable hydromorphone (HDM) and diacetylmorphine …
opioid treatments, the scale-up of injectable hydromorphone (HDM) and diacetylmorphine …
Feasibility of testing client preferences for accessing Injectable opioid agonist treatment (iOAT): a pilot study
S Dobischok, RK Metcalfe, EA Matzinger… - Patient preference …, 2022 - Taylor & Francis
Purpose Injectable opioid agonist treatment (iOAT) is an effective treatment for opioid use
disorder (OUD). To our knowledge, no research has systematically studied client …
disorder (OUD). To our knowledge, no research has systematically studied client …
[HTML][HTML] The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19
Background The dual COVID-19 and overdose emergencies amplified strain on healthcare
systems tasked with responding to both. One downstream consequence of the pandemic in …
systems tasked with responding to both. One downstream consequence of the pandemic in …